Third Point Calls for Board to Sell Acorda Therapeutics, Inc.
NEW YORK, Feb. 22 /PRNewswire/ -- Third Point LLC today announced that it has filed a Schedule 13D with the Securities and Exchange Commission calling upon the Board of Directors of Acorda Therapeutics, Inc. (NASDAQ:ACOR) to initiate a process to sell the Company in its entirety, and that the following letter has been... More...>>

LSE and PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2008 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: :: Press office ::

ADDITIONAL SERVICES AVAILABLE FROM ADVFN
					ADVFN Forex Channel Exchange Rates, FX Prices Charts, Forex Brokers & Currency Conversion

32 site:2gb nasdaq acor081122 15:46